[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100600097":3},{"organization":4,"armGroups":7,"interventions":34,"overallOfficials":58,"centralContacts":59,"locations":68,"responsibleParty":88,"collaborators":58,"id":92,"slug":93,"hasResults":94,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":100,"sex":101,"minAge":102,"maxAge":103,"enrollmentInfo":104,"targetDuration":58,"studyType":107,"phases":108,"briefSummary":110,"conditions":111,"keywords":113,"overallStatus":71,"whyStopped":58,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":121,"completionDateStruct":123,"leadSponsor":125,"locationsCount":126},{"fullName":5,"class":6},"University of Electronic Science and Technology of China","OTHER",[8,15,20,25,30],{"label":9,"type":10,"description":11,"interventionNames":12},"oxytocin 24IU group","EXPERIMENTAL","Interventions are placebo followed after 15 min by the lower dose (24IU) oxytocin",[13,14],"Drug: Oxytocin lower dose (24IU)","Drug: Placebo",{"label":16,"type":10,"description":17,"interventionNames":18},"atosiban group","Interventions are placebo followed after 15 minutes by 150ug atosiban",[19,14],"Drug: Atosiban",{"label":21,"type":22,"description":23,"interventionNames":24},"placebo group","PLACEBO_COMPARATOR","Interventions are placebo followed after 15 minutes by another placebo",[14],{"label":26,"type":10,"description":27,"interventionNames":28},"oxytocin 48IU group","Interventions are placebo followed after 15 minutes by the higher 48IU oxytocin dose",[29,14],"Drug: Oxytocin higher dose (48IU)",{"label":31,"type":10,"description":32,"interventionNames":33},"Atosiban and 24IU oxytocin group","Interventions are atosiban 150ug followed after 15 minutes by the lower (24IU) dose of oxytocin",[13,19],[35,42,48,54],{"type":36,"name":37,"description":38,"armGroupLabels":39,"otherNames":40},"DRUG","Oxytocin lower dose (24IU)","Oxytocin (24IU) will be administered as a lingual spray (6, 0.1 puffs (4IU per puff) of spray on and under the tongue)",[31,9],[41],"oral oxytocin 24IU",{"type":36,"name":43,"description":44,"armGroupLabels":45,"otherNames":46},"Oxytocin higher dose (48IU)","48IU oxytocin administered as a lingual spray (6, 0.1ml sprays (8IU per puff) on or under the tongue)",[26],[47],"oral oxytocin 48IU",{"type":36,"name":49,"description":50,"armGroupLabels":51,"otherNames":52},"Atosiban","150ug atosiban administered by lingual sprays (6, 0.1ml sprays on and under the tongue)",[31,16],[53],"oral atosiban",{"type":36,"name":55,"description":56,"armGroupLabels":57,"otherNames":58},"Placebo","Placebo administered as a lingual spray (6, 0.1 ml sprays one and under the tongue. Placebo has the same composition of 0.9% saline and glycerol as for oxytocin and atosiban interventions",[16,9,26,21],null,[60,65],{"name":61,"role":62,"phone":63,"phoneExt":58,"email":64},"Keith M Kendrick, PhD","CONTACT","86-28-61830811","k.kendrick.uestc@gmail.com",{"name":66,"role":62,"phone":67,"phoneExt":58,"email":58},"Yige Wang, PhD","86+13086688860",[69],{"facility":70,"status":71,"city":72,"state":73,"zip":74,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":82,"contacts":83},"School of Life science and Technology, University of Electronic Science and Technology of China","RECRUITING","Chengdu","Sichuan","611731","China","CN",{"type":78,"coordinates":79},"Point",[80,81],104.06667,30.66667,{"lat":81,"lon":80},[84],{"name":85,"role":62,"phone":86,"phoneExt":58,"email":87},"Yan Zhang, MSc","+86 18215678419","532769737@qq.com",{"type":89,"investigatorFullName":90,"investigatorTitle":91,"investigatorAffiliation":5,"oldNameTitle":58,"oldOrganization":58},"PRINCIPAL_INVESTIGATOR","Keith Kendrick","Professor","100600097","early-phase-1-the-effect-of-oral-oxytocin-and-atosiban-on-social-attention-100600097",false,"NCT07093060","The Effect of Oral Oxytocin and Atosiban on Social Attention","The Influence and Regulatory Role of Exogenous and Endogenous Oxytocin on Social Attention in Humans","OTAtosiban","Inclusion Criteria:\n\n* Healthy male subjects without past or current psychiatric or neurological disorders\n\nExclusion Criteria:\n\n* History of or current neurological\u002Fpsychiatric disorders;\n* Use of psychotropic medications (including nicotine)\n* Visual impairments",true,"MALE","18 Years","35 Years",{"count":105,"type":106},250,"ESTIMATED","INTERVENTIONAL",[109],"EARLY_PHASE1","The main aim of the present study is to investigate whether orally (lingual spray) administered oxytocin influences human social attention and behaviors via oxytocin receptors and whether its effects are dose- and task-dependent.",[112],"Healhty",[114,49,115,116],"Oxytocin","Eye tracking","Autistic trait","2025-07-28",{"date":119,"type":120},"2025-07-30","ACTUAL",{"date":122,"type":120},"2025-06-09",{"date":124,"type":106},"2025-11-30",{"name":5,"class":6},1]